A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00682981
Recruitment Status : Completed
First Posted : May 23, 2008
Last Update Posted : July 21, 2016
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Gemin X )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2011
  Study Completion Date : November 2011
  Certification/Extension First Submitted : August 27, 2013